J9292
HCPCSInj, pemetrexed dipotassium
Official HCPCS Level II long descriptor
Injection, pemetrexed dipotassium, 10 mg
HCPCS Level II code J9292 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, pemetrexed dipotassium
Added to HCPCS: 2025-01-01
Nearby codes in J9
- J9277Pembrolizumab 1mg berahyalur
- J9278Inj, carboplatin (avyxa)
- J9280Mitomycin injection
- J9281Mitomycin instillation
- J9282Mitomycin intravesical inst
- J9285Inj, olaratumab, 10 mg
- J9286Inj glofitamab gxbm, 2.5 mg
- J9289Inj nivolumab 2 mg hyaluron
- J9293Mitoxantrone hydrochl / 5 mg
- J9294Inj pemetrexed, hospira 10mg
- J9295Injection, necitumumab, 1 mg
- J9296Inj pemetrexed (accord) 10mg
- J9297Inj pemetrexed (sandoz) 10mg
- J9298Inj nivol relatlimab 3mg/1mg
- J9299Injection, nivolumab
- J9301Obinutuzumab inj
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.